Pilulka's Market Expansion and Innovation slide image

Pilulka's Market Expansion and Innovation

4.3 NETWORK OF PARTNER AND OWN BRICK-AND-MORTAR PHARMACIES nákup z pilulka.c vyzvedněte ditě a matka 0000 péče o tělo body care میدا 4% Projected average annual growth of brick-and-mortar pharmacies revenues in 2023 - 2026 The network of brick-and-mortar pharmacies complements the online services offered by Pilulka, increases brand awareness and improves the Company's bargaining position with suppliers. Stone pharmacies also allow the personal pick-up of online orders Currently, 107 pharmacies across the Czech Republic operate under the Pilulka brand. In addition to its own pharmacies (23 branches), the Company is also developing a franchise concept, under which independent pharmacy operators have the opportunity to take advantage of Pilulka's marketing support As a result of its primary focus on the development of online activities, the Company currently does not anticipate the further expansion of its own pharmacy network. In recent years, the Company has optimised the network and divested unprofitable units, which has resulted in a reduction in the total revenues generated by the network. The main tool for strengthening Pilulka's presence on the brick-and-mortar pharmacy market in the future will be the franchise concept. The presented revenues growth outlook does not assume a substantial increase in the number of franchised pharmacies, but rather an organic growth within the current network 107 pharmacies of Pilulka, 23 own and 84 partner pharmacies Revenues from the network of own pharmacies have been declining in recent years due to the optimisation of the network and the sale of unprofitable units In the COVID-19 period, the Company was primarily focused on the development of online activities Management now plans to further develop and expand the franchise concept as the primary tool to further penetrate an offline segment CZK billion Actuals Forecast 1.4 1.2 1.0 0.8 0.6 0.4 0.2 0.0 2020 2021 2022 2023E 2024P 2025P 2026P Note: The presented financial data are based on the Company's management accounting Revenues CZ - partner's pharmacies Prescription drugs 55% Revenues CZ - own pharmacies Structure of Pilulka offline revenues (1) Over-the- counter medicines 32% Food supplements / cosmetics 13% Note: (1) Revenues realized in January - December 2022 11 +pilulka
View entire presentation